FERNE/EMRA How do we treat ICH patients with an elevated INR Andy Jagoda, MD, FACEP Professor and Vice Chair Department of Emergency Medicine Mount Sinai.

Slides:

Advertisements

Similar presentations

Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.

Advertisements

CNS Alphabet Soup: CVA, ICH, SAH. Patient Case Presentations,

TREATMENT Coagulopathy of Liver Failure. Fresh Frozen Plasma – Most effective way to correct hemostasis in patients with liver failure – Infusion (5-10mL/kg)

Heather Prendergast, MD, MPH, FACEP EMRA/FERNE Mid-Atlantic Emergency Medicine Student Symposium: The ABCs of Head CT Interpretation in the ED.

What a Bloody Mess! A/Professor Kent Robinson Senior Staff Specialist, Liverpool & Campbelltown Hospitals.

Edward P. Sloan, MD, MPH Optimizing the Management of Emergency Department Intracerebral Hemorrhage Patients FERNE Satellite 2005 ACEP Scientific Assembly.

Edward P. Sloan, MD, MPH, FACEP FERNE Brain Illness and Injury Course.

Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.

Blood Components Dosage And Their Administration

Edward P. Sloan, MD, MPH, FACEP Diagnosing & Treating Emergency Department CNS Hemorrhage Patients.

Optimal Management of Hypertensive Emergency Patients: Clinical Scenarios and Panel Discussion.

Edward P. Sloan, MD, MPH, FACEP Stroke Patient Care in the Prehospital and ED Settings: Should EMS Triage & Inter-hospital Transfer Occur?

Andrew W. Asimos, MD Treating CNS Hemorrhage in the Anticoagulated Patient.

ICEP Academic Forum April 29, 2004 Northwestern Memorial Hospital.

Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.

Transfusing tiny soldiers Ramsey C. Tate, MD. Applying combat-derived massive transfusion protocols to pediatric trauma patients.

MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.

Edward P. Sloan, MD, MPH FACEP ED Transient Ischemic Attack Patient Management: What Role for Outpatient Evaluation and Disposition?

Clinical Policy / Practice Guideline Development Andy Jagoda, MD, FACEP Professor of Emergency Medicine Mount Sinai School of Medicine New York, New York.

Edward P. Sloan, MD, MPH, FACEP ED Hemorrhagic Stroke Patient Management: What Role for Operative Intervention & Factor VIIa?

Andy Jagoda, MD, FACEP The Role of Emergency Medicine in Neurologic Emergencies Andy Jagoda, MD, FACEP Professor of Emergency Medicine Mount Sinai School.

Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures Andy Jagoda, MD, FACEP Professor of Emergency.

Edward P. Sloan, MD, MPH, FACEP Emergency Department Ischemic Stroke Pt Care : Advanced Diagnostics and Therapeutics.

Edward P. Sloan, MD, MPH FERNE/EMRA Session: SIM Wars Residency Simulation Competition: A Model for Learning Neurological Emergencies.

Andy Jagoda, MD, FACEP Stroke and TIA Patients in the Prehospital and ED Settings: Should EMS Triage and Inter-hospital Transfer to Stroke Centers Take.

J. Stephen Huff, MD, FACEP J. Stephen Huff, MD Associate Professor Department of Emergency Medicine University of Virginia Charlottesville, Virginia.

Edward P. Sloan, MD, MPH, FACEP Emergency Department Patient Hypertensive Emergencies: Published Guidelines, Articles, & Their Findings.

FERNE/MEMC Session: Treating Ischemic Stroke in the 3 – 4

Systems in Acute Stroke Care Andy Jagoda, MD Professor of Emergency Medicine Department of Emergency Medicine Mount Sinai School of Medicine New York,

Edward P. Sloan, MD, MPH, FACEP EMRA /FERNE Case Conference: The ED Management of TIA, AIS and ICH Patients.

Edward P. Sloan, MD, MPH, FACEP Emergency Department Hypertensive Patient Emergencies: Case Presentations and Panel Discussion.

Edward P. Sloan, MD, MPH, FACEP Diagnosing & Treating ED CNS Hemorrhage Patients.

A Case of Acute Spinal Trauma Andy Jagoda, MD, FACEP.

Andres Ferber MD September

A Case of a Thunderclap Headache Andy Jagoda, MD, FACEP.

Background Methods Results Conclusion Acknowledgements Printed by Multi-Institutional Audit of octaplex® & Comparison with National Recommendations S.

Care of the Anti-coagulated Trauma Patient Julie Mayglothling, MD, FACEP Emergencies in Medicine March 8 th, 2012.

CNS Panel CNS Alphabet Soup: CVA, ICH, SAH Patient Case Presentations, ED Diagnosis and Management.

Edward P. Sloan, MD, MPH Case Studies in Cerebrovascular Emergencies Research:

Emergency anticoagulant reversal B Vigué, DAR, CHU Bicêtre.

Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.

Edward P. Sloan, MD, MPH, FACEP Optimizing ED TIA and Ischemic Stroke Patient Care.

1 Ultra-rapid management of oral anticoagulant therapy- related surgical intracranial hemorrhage Intensive Care Medicine (2007) 33: Zohra Daw, MD,

Edward P. Sloan, MD, MPH, FACEP Ischemic Stroke Patient Care: tPA Use in 2007.

FERNE/EMRA ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED (mimickers, stroke scales, and CT interpretation)?

Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)

Anticoagulants and reversal

General principles for preventing high INR Simple dental or dermatological procedures may not require interruption to warfarin therapy. Simple dental.

Factor Eight Inhibitor Bypassing Activity (FEIBA) for the Rapid Reversal of Major Bleeding in Patients with Warfarin Induced Coagulopathy: A Pilot Study.

Fred V. Plapp MD PhD Pathology and Laboratory Medicine

Richard Shih, MD, FACEP Stroke Patient Management Using IV tPA: When and How Should It Be Utilized in ED Patients?

Management of Spontaneous ICH Corey Heitz, MD Director, Undergrad Med Ed Assistant Professor, Emergency Medicine.

April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 1: Warfarin.

Approach To Bleeding Disorders In Neonates

Prothrombin Complex Concentrate- Octaplex

AUB:Iatrogent Coagulopathy

Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.

Warfarin Toxicity Treatment & Management

Evaluation of Four Factor Prothrombin Complex Concentrate

Anticoagulation Prepared by Cherie Gan.

Oral Anticoagulants and Reversal Agents

Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents.

Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.

Reversal of Direct Oral Anticoagulants (DOAC)

Anticoagulant Reversal

 INDICATIONS AND USAGE  DOSAGE AND ADMINISTRATION  DOSAGE FORMS AND STRENGTHS  WARNINGS AND PRECAUTIONS  ADVERSE REACTIONS  USE IN SPECIFIC POPULATIONS.

A. Kisilevsky, A.W. Gelb, M. Bustillo, A.M. Flexman

VKA Reversal and LVADs.

Blood Components Dosage And Their Administration

Use Fixed low dose Prothrombin Complex Concentrate (Octaplex)

Presentation transcript:

FERNE/EMRA How do we treat ICH patients with an elevated INR Andy Jagoda, MD, FACEP Professor and Vice Chair Department of Emergency Medicine Mount Sinai School of Medicine New York, NY

FERNE/EMRA Disclosures Astra Zeneca, NovoNordisk, UCB Pharma Advisory Boards Astra Zeneca, NovoNordisk, UCB Pharma Advisory Boards Eisai Speakers’ Bureau Eisai Speakers’ Bureau Chair, ACEP Clinical Policies Committee Chair, ACEP Clinical Policies Committee Executive Board, Brain Attach Coalition Executive Board, Brain Attach Coalition Executive Board, Foundation for Education and Research in Neurologic Emergencies Executive Board, Foundation for Education and Research in Neurologic Emergencies

FERNE/EMRA Common Etiologies of ICH  Incidence of anticoagulant-associated ICH rose from 5% to 18% of cases of spontaneous ICH in 1990s  INR increases risk of ICH 10X  ICH expansion in over 50% of patients on warfarin  Doubles ICH mortality Acquired Coagulopathy – Anticoagulation

FERNE/EMRA Treatment ICH in patients with INR > 1.5 is life- threatening ICH in patients with INR > 1.5 is life- threatening Time until initiation of warfarin reversal is predictive of outcome Time until initiation of warfarin reversal is predictive of outcome Reversal may not occur in 1 of 6 patients Reversal may not occur in 1 of 6 patients Goldstein JN, et al. Stroke. 2006;37:

FERNE/EMRA Reversal Options Fresh frozen plasma (FFP)Fresh frozen plasma (FFP)  Administration time  Response time Recombinant factor VIIaRecombinant factor VIIa  Limited experience Prothrombin complex concentrates (PCC)Prothrombin complex concentrates (PCC)  Not available Vitamin KVitamin K

FERNE/EMRA Trauma Model Tx of trauma patients with ICH on preinjury warfarin. J Trauma 2006; 61: “Coumadin protocol” in place “Coumadin protocol” in place Mean time until FFP administration was 4.3 hours +/- 4.4 hours Mean time until FFP administration was 4.3 hours +/- 4.4 hours No difference from the preprotocol group No difference from the preprotocol group Reasons for delay: Reasons for delay: Failure to recognize urgency Failure to recognize urgency Delay in delivery from blood bank Delay in delivery from blood bank Delay in initiation of infusion Delay in initiation of infusion Delay in completion of infusion Delay in completion of infusion

FERNE/EMRA Stroke Model Timing of FFP administration. Stroke 2006; 37: CT to FFP time: 60 – 375 min CT to FFP time: 60 – 375 min FFP: 1 – 6 units FFP: 1 – 6 units Vit K: 0 – 10 mg Vit K: 0 – 10 mg 12 / 57 patients INR did not reverse at 24 hours 12 / 57 patients INR did not reverse at 24 hours Rapid correction of INR did not correlate with outcome Rapid correction of INR did not correlate with outcome Delay in presentation Delay in presentation Delay in administration Delay in administration Delay in reversal Delay in reversal

FERNE/EMRA Conclusions Protocols need to exist to facilitate rapid reversal of warfarin induced coagulopathy Protocols need to exist to facilitate rapid reversal of warfarin induced coagulopathy Protocol: Protocol: units FFP; begin with 2 units of universal donor FFP units FFP; begin with 2 units of universal donor FFP 10 mg Vit K slowly IV over 10 minutes 10 mg Vit K slowly IV over 10 minutes Need for further research on the role of rFactor VII and PCC Need for further research on the role of rFactor VII and PCC